Liver metastases
Liver metastases are commonly detected in a range of malignancies including colorectal
cancer (CRC), pancreatic cancer, melanoma, lung cancer and breast cancer, although CRC …
cancer (CRC), pancreatic cancer, melanoma, lung cancer and breast cancer, although CRC …
Tumor targeting via EPR: Strategies to enhance patient responses
The tumor accumulation of nanomedicines relies on the enhanced permeability and
retention (EPR) effect. In the last 5–10 years, it has been increasingly recognized that there …
retention (EPR) effect. In the last 5–10 years, it has been increasingly recognized that there …
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …
Treatment of metastatic colorectal cancer: ASCO guideline
PURPOSE To develop recommendations for treatment of patients with metastatic colorectal
cancer (mCRC). METHODS ASCO convened an Expert Panel to conduct a systematic …
cancer (mCRC). METHODS ASCO convened an Expert Panel to conduct a systematic …
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
M Weber, M Lam, C Chiesa, M Konijnenberg… - European journal of …, 2022 - Springer
Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
Purpose A multidisciplinary expert panel convened to formulate state-of-the-art
recommendations for optimisation of selective internal radiation therapy (SIRT) with yttrium …
recommendations for optimisation of selective internal radiation therapy (SIRT) with yttrium …
Modern therapeutic approaches for the treatment of malignant liver tumours
H Petrowsky, R Fritsch, M Guckenberger… - Nature reviews …, 2020 - nature.com
Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …
PLGA-based nanoparticles in cancer treatment
S Rezvantalab, NI Drude, MK Moraveji… - Frontiers in …, 2018 - frontiersin.org
Nanomedicines can be used for a variety of cancer therapies including tumor-targeted drug
delivery, hyperthermia, and photodynamic therapy. Poly (lactic-co-glycolic acid)(PLGA) …
delivery, hyperthermia, and photodynamic therapy. Poly (lactic-co-glycolic acid)(PLGA) …
[HTML][HTML] Colorectal liver metastases: Current management and future perspectives
J Martin, A Petrillo, EC Smyth, N Shaida… - World Journal of …, 2020 - ncbi.nlm.nih.gov
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …
at least 25% developing colorectal liver metastases (CRLM) during the course of their …
Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial
MF Mulcahy, A Mahvash, M Pracht… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To study the impact of transarterial Yttrium-90 radioembolization (TARE) in
combination with second-line systemic chemotherapy for colorectal liver metastases (CLM) …
combination with second-line systemic chemotherapy for colorectal liver metastases (CLM) …